
Eugene Pietzak, MD, highlights the background and design of the ongoing phase 3 GAIN trial, exploring the combination of gemcitabine and BCG in BCG-exposed NMIBC.

Eugene Pietzak, MD, is a urologic surgeon at Memorial Sloan Kettering Cancer Center in New York, New York.